1. Home
  2. Vaccine Safety

Vaccine Safety

Fecha
Blood clots and covid vaccines
Blood Clots and COVID-19 vaccines: Materials
GBS and covid vaccines
Guillain-Barré Syndrome and COVID-19 vaccines: materials
The best vaccine
The Best Vaccine - Social media collection
vaccine safety IG
How to monitor and report COVID-19 vaccines side effects
heart inflammation and covid19 vaccines
Heart inflammation and mRNA COVID-19 vaccines - Materials
covid-19 vaccines
Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on reports of Guillain-Barré Syndrome (GBS) following adenovirus vector COVID-19 vaccines
tts management
Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (‎TTS)‎ following vaccination to prevent coronavirus disease (‎COVID-19)‎: interim guidance, 19 July 2021
COVID-19 VACCINE
COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS): updated guidance regarding myocarditis and pericarditis reported with COVID-19 mRNA vaccines
COVID-19 VACCINE
COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS) reviews cases of mild myocarditis reported with COVID-19 mRNA vaccines
typical side effects COVID-19 vaccine
Typical side effects of the COVID-19 vaccine are:
covid-19 vaccines
Statement for healthcare professionals: How COVID-19 vaccines are regulated for safety and effectiveness
COVID-19 VACCINE
Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on safety signals related to the AstraZeneca COVID-19 vaccine
COVID-19 VACCINE
Statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS) on safety signals related to the Johnson & Johnson/Janssen COVID-19 vaccine
side effects
Side Effects of COVID-19 Vaccines
covid-19 vaccine safety
Getting the COVID-19 Vaccine
safety of covid-19 vaccines
Safety of COVID-19 Vaccines
thrombotic events
Considerations on Thrombotic Events Following Administration of the AstraZeneca COVID-19 Vaccine in Europe, 7 April 2021
AstraZeneca
Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on safety signals related to the AstraZeneca COVID-19 vaccine